Navigation Links
Questcor to Commence Phase 2 Study of Acthar for ALS
Date:7/24/2013

l need such as ALS. Questcor also has agreed to acquire certain international rights for Synacthen® (tetracosactide) and Synacthen Depot®, and has licensed the right to develop and seek FDA approval for these products in the United States.  For more information about Questcor, please visit www.questcor.com.  For more information about Acthar, including important safety information, please visit www.acthar.com.

Note: Except for the historical information contained herein, this press release contains forward-looking statements that have been made pursuant to the Private Securities Litigation Reform Act of 1995. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as "believes," "continue," "could," "estimates," "expects," "growth," "intent," "may," "plans," "potential," "should," "substantial," "will," or "would" or the negative of such terms and other comparable terminology. These statements are only predictions. Actual events or results may differ materially. Factors that could cause or contribute to such differences include, but are not limited to, the following:

  • Research and development risks, including risks associated with Questcor's work in the area of ALS;
  • Our reliance on Acthar for substantially all of our net sales and profits;
  • The lack of patent protection for Acthar; and the possible FDA approval and market introduction of competitive products;
  • The results of any pending or future litigation, investigations or claims, including with respect to the investigation by the United States Attorney's Office for the Eastern District of Pennsylvania regarding the Company's promotional practices and litigation brought by certain
    '/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Questcor to Report Second Quarter Financial Results on July 30, 2013
2. Questcor to Initiate Pilot Commercialization Effort In Pulmonology for Symptomatic Sarcoidosis
3. Ongoing Clinical Trials Reveal Groundbreaking Results - Research Report on Alexion, BioMarin, Onyx, Questcor, and ImmunoGen
4. Questcor Adds Angus C. Russell to Board of Directors
5. Questcor Reports First Quarter Financial Results
6. Questcor to Report First Quarter Results on April 30, 2013
7. Questcor Reports Fourth Quarter and Full Year 2012 Results
8. Questcor to Report Fourth Quarter and Full Year 2012 Financial Results on February 26, 2013
9. Questcor Pharmaceuticals Appoints Michael Aldridge to the Position of Senior Vice President, Corporate Strategic Development
10. Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
11. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , 21 de noviembre de 2014  BioClinica®, ... clínicos externalizados y tecnologías eClinical, ha indicado un ... ,seguimiento inteligente, para el seguimiento basado en el ... amplía el concepto del seguimiento basado en el ... las visitas de seguimiento o cambio de los ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/22/2014)... 2014  Particle Sciences, Inc (PSI), the leading ... manufactured a new innovative vaginal ring for Ladee ... arm of Exeltis Pharmaceuticals.  According to Bruce ... Particle Sciences, "This vaginal ring was developed for ... and modeling expertise.  We are thrilled it is ...
Breaking Medicine Technology:El 'seguimiento inteligente' consigue un excelente momento 2El 'seguimiento inteligente' consigue un excelente momento 3Alarming Stats Show Holiday Drinking an Issue for Many 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2
... Time - SOUTH SAN FRANCISCO, Calif., March 16 ... biopharmaceutical company focused on oncology, today reported financial results ... 2008, and provided a corporate update. "During the fourth ... goal of developing picoplatin as an oncology platform compound ...
... announced that it has initiated a Phase II clinical ... ulcers. HP802-247 is a topical spray containing living keratinocytes ... effectiveness of two cell concentrations and two dosing frequencies ... placebo plus standard care, in healing venous leg ulcers ...
Cached Medicine Technology:Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 2Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 3Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 4Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 5Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 6Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 7Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 8Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update 9Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 2Healthpoint Initiates Phase II, Dose-Finding Study to Evaluate Effectiveness of a Unique Cell Based Therapy in Venous Leg Ulcers 3
(Date:11/21/2014)... City, Mo (PRWEB) November 21, 2014 ... received the Get With The Guidelines®–Heart Failure Gold-Plus ... measures outlined by the American Heart Association/American College ... for heart failure patients. , Get With The ... helps hospital teams provide the most up-to-date, research-based ...
(Date:11/21/2014)... Big Bud Farms announced today that they ... with Ed Begley Jr., airing via Discovery Channel 2nd ... Bud Farms, growers of legal medical marijuana, provide the ... medical marijuana. , This segment of Innovations takes a ... products for medicating. Viewers will learn about the resources ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Recently, ... and launched a wedding dress promotion for the coming ... enjoy a special offer when checking out. , The ... in 2014. The customers like the designs for the ... VogueQueen.com would not only be good for the environment, ...
(Date:11/21/2014)... DC (PRWEB) November 21, 2014 Midway ... Atlantic Information Services, Inc.’s (AIS) annual Directory of Health ... plan market. AIS’s Directory of Health Plans is a ... health plans operating in the U.S. The 2015 ... far, researchers in AIS’s Directory and Databases Division, the ...
(Date:11/21/2014)... 21, 2014 TruDenta, the creator of ... and other jaw-related symptoms, has reported a nationwide ... chronic head pain, neck pain, TMJ (temporomandibular joint) disorder, ... we have seen a 52% increase in the number ... over 300 doctors and their teams in 47 states ...
Breaking Medicine News(10 mins):Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2Health News:National Rise In Patients Seeking Headache Relief 2
... On-Site Messaging Software offers key functionality & improved accountability. , ... ... Interpage L.P. has recently released the newest version of Enterprise 101 ... create & send a custom priority, pre-defined, or emergency alert message ...
... is forecast to experience robust growth and is on course to ... a growing number of individuals suffering from common chronic diseases represent ... ... (PRWEB) October 29, 2008 -- Significant dimensions of the vast parallel ...
... of online degree programs , ... Spokane (PRWEB) October ... university based in Spokane, has announced the addition of a revised ... of online degree programs, which includes a Master in Organizational Leadership ...
... Royle Family star Ricky Tomlinson , ... (PRWEB) October 29, 2008 -- ... Heart Disease (CHD) as part of a new campaign for Lloydspharmacy. Ricky ... the past and paid the price in 2007 when he was diagnosed ...
... Raptor,Pharmaceuticals Corp. (OTC Bulletin Board: RPTP), today announced that,senior management ... healthcare investor conferences:, -- The 7th Annual BIO ... Palace Hotel in San Francisco, CA. Raptor,s ... October 29 at 4:45pm ET (1:45pm PT) in Telegraph ...
... WellPoint (NYSE: WLP ) announced,that Angela Braly, president ... in Norfolk, Va. this evening. Ms. Braly focused on ... to come together to improve,both access to care and ... the progress we have made in the past few ...
Cached Medicine News:Health News:InterPage L.P. Announces New Enhancements to Enterprise 101 Messaging Solution 2Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 2Health News:World Biochips Market to Reach $3.4 billion by 2012, According to New Report by Global Industry Analysts, Inc. 3Health News:Gonzaga Online Updates Communications Masters Program To Meet the Needs of Today's Professionals 2Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 2Health News:Ricky Tomlinson Joins Lloydspharmacy Against Coronary Heart Disease 3Health News:Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences 2Health News:Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences 3Health News:Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences 4Health News:WellPoint President and CEO Angela Braly Appears at the Norfolk Forum 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: